Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Kazia Therapeutics (KZIA – Research Report), EyePoint Pharmaceuticals (EYPT – Research Report) and Oramed Pharmaceuticals (ORMP – Research Report).
Kazia Therapeutics (KZIA)
H.C. Wainwright analyst Sean Lee CFA downgraded Kazia Therapeutics to Hold today. The company’s shares closed last Monday at $1.92, close to its 52-week low of $1.63.
According to TipRanks.com, CFA has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The the analyst consensus on Kazia Therapeutics is currently a Hold rating.
EyePoint Pharmaceuticals (EYPT)
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on EyePoint Pharmaceuticals, with a price target of $24.00. The company’s shares closed last Monday at $9.11, close to its 52-week low of $7.00.
According to TipRanks.com, Chen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for EyePoint Pharmaceuticals with a $22.50 average price target, implying a 150.0% upside from current levels. In a report issued on July 19, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $31.00 price target.
Oramed Pharmaceuticals (ORMP)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Oramed Pharmaceuticals, with a price target of $32.00. The company’s shares closed last Monday at $8.36.
According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Oramed Pharmaceuticals with a $31.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on KZIA:
- Analysts Offer Insights on Technology Companies: Lattice Semiconductor (LSCC), Nutanix (NTNX) and Pinterest (PINS)
- Amgen’s Row with IRS over $10.7B Tax Bill
- Axonics Modulation Technologies (AXNX) Received its Third Buy in a Row
- Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Teladoc (TDOC) and Anavex Life Sciences (AVXL)
- Tower Semiconductor Reports Second Quarter 2022 Record Revenue of $426 Million Year over Year Revenue Growth of 18% Total and 30% Organic